Natural product-derived therapy for enhancing anti-cancer immunity: Curcumin analog EF24 decreases the level of LATS1/2 (large tumor suppressor 1 and 2), increases immunogenicity of tumors, enhances anti-tumor immune responses, and inhibits tumor growth via down regulation of its target gene, 19/December/2016, 10.27 am

Natural product-derived therapy for overcoming chemoresistance in Human cancers: Honokiol increases the expression of CADM1, decreases BMI1 translocation, increases tumor suppressor INK4a/p16 expression and restores chemosensitivity in drug-resistant Human cancers via down regulation of its target gene, 18/December/2016, 11.01 pm
December 18, 2016
Small molecule-based PD-1 pathway blockade for Human cancer therapy: UBTD1 (Ubiquitin domain containing 1) inhibits the expression of co-inhibitory receptor PD-1 on Antigen- Specific T-cells, increases the production of cytokines by tumor-infiltrating lymphocytes (TIL), and draining lymph nodes and augments anti-tumor activity via down-regulation of its target gene, 19/December/2016, 9.49 pm
December 19, 2016
Show all

Introduction: What they say

A study from the Department of Pharmacology and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA shows that “The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.” This study was published in the 1 December 2016 issue of the journal “Cell” [the number 1 journal in General Biology with an I.F of 28.710] by Prof. Guan KL, Moroishi T, and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-derived  therapy for enhancing anti-cancer immunity:  Curcumin analog EF24 decreases the level of LATS1/2 (large tumor suppressor 1 and 2), increases immunogenicity of tumors, enhances anti-tumor immune responses, and inhibits tumor growth via down regulation of its target gene


From Significance of the study to Public health relevance:

Given that: (i) each year nearly 14 million people are diagnosed with cancer globally, and little more than half of them will die; (ii) cancer deaths globally are expected to be doubled by 2030; (iii) cancer treatment causes the highest economic loss compared to all the known causes of death worldwide, there is an urgent need to find: (i) a way to prevent an individual from being susceptible to cancer by strengthening his/her own immune system; (ii) a cheaper alternative to the existing expensive anticancer drugs; (ii) a side-effect-free natural product-based drug; and (iii) a way to effectively treat and prevent metastatic progression and relapse of cancers.


What we infer from what they say:

Prof. Guan’s research team has recently shown that deletion of Lats1/2 in tumor cells: (1) augments  cytotoxic T cells activity; (2) enhances antibody production by B-cells; (3) enhances anti-tumor immunity by stimulating TLRs-MYDD/TRIF-IFN-I pathway; (4) enhances YAP (Yes-associated protein) activity; and (5) augments tumor vaccine efficacy, suggesting that inhibition of LATS1/2 expression in cancer cells will augment immune system’s ability to prevent tumor growth.


From research findings to therapeutic opportunity : 

This study suggests a natural product-derived therapy for augmenting anti-cancer immunity. Curcumin, one of the main components of turmeric, is known to function as an anticancer agent (fig. 1). However, the detailed mechanistic insights is yet to emerge. EF24 is a structural analog of Curcumin. EF24, by decreasing the expression of its target genes, it may decrease the expression of LATS1/2 (fig. 3).

price-quote[easy_payment currency=”USD”]

Thereby, it may: (i) enhance Cytotoxic T-cell activity and antibody production by B-cells; (ii) enhance anti-tumor immunity via Interferon-I pathway (TLRs-MYDD/TRIF); (iii) increase the expression of transcriptional coactivator YAP, possibly, its target gene p53 homologue TAp73; (iv)  increase tumor vaccine efficacy; and (v) promote tumor regression (fig.3).

Curcumin, one of the main component of Turmeric,

Figure 1. Curcumin analog EF24, one of the main components of Turmeric, stimulates and strengthens anti-cancer immunity by down regulating  the expression of LATS1/2

Image result for curcumin EF24

Figure 2. Curcumin analog EF24

curcumin-analog-ef24-suppresses-lats1-or-2-expression-to-augment-anticancer-immunity

Figure 3. Mechanistic insights into how EF24 suppresses the expression of Lats1/2 to promote tumor regression.

Thus, pharmacological formulations encompassing “EF24 or its analogues or EF24 in combination with other known anticancer drugs(fig. 2) may be used to strengthen cancer patients immune system to prevent tumor growth and cancer progression.


Details of the Research findings:  

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Amount: $500#

Undisclosed information: How does Curcumin analog EF24 decrease the expression of LATS1/2 to inhibit tumor growth?

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

For purchase and payment details, you may reach us at info@genomediscovery.org

#Research cooperation


References: 

Web: http://genomediscovery.org or http://newbioideas.com

Citation: Boominathan, L., Natural product-derived  therapy for enhancing anti-cancer immunity:  Curcumin analog EF24 decreases the level of LATS1/2 (large tumor suppressor 1 and 2), increases immunogenicity of tumors, enhances anti-tumor immune responses, and  inhibits tumor growth via down regulation of its target gene, 19/December/2016, 10.27 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite, Kindly drop us a line at admin@genomediscovery.org

Comments are closed.